**Author details**

Emmanuel Drouet HIV and Persisting Viruses Lab, Institut de Biologie Structurale, Grenoble-Alpes University, Grenoble, France

\*Address all correspondence to: emmanuel.drouet@ibs.fr

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**109**

2014;**26**:60-68

2005;**15**:3-15

*The Role of the Epstein-Barr Virus Lytic Cycle in Tumor Progression: Consequences in Diagnosis…*

[10] Rickinson AB, Long HM, Palendira U, Munz C, Hislop AD. Cellular immune controls over Epstein-Barr virus infection: New lessons from the clinic and the laboratory. Trends in

Immunology. 2014;**35**:159-169

Letters. 2011;**305**:163-174

[11] Cesarman E. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer

[12] Dierickx D, Habermann TM. Posttransplantation lymphoproliferative disorders in adults. The New England Journal of Medicine. 2018;**378**:549-562

[13] Morales-Sanchez A, Fuentes-Panana EM. The immunomodulatory capacity of an Epstein-Barr virus abortive lytic cycle: Potential contribution to viral tumorigenesis. Cancers (Basel). 2018;**10**:1-25

[14] Manners O, Murphy JC, Coleman A, Hughes DJ, Whitehouse A. Contribution of the KSHV and EBV lytic cycles to tumourigenesis. Current Opinion in

[15] Jha HC, Banerjee S, Robertson ES. The role of gammaherpesviruses in Cancer pathogenesis. Pathogens. 2016;**5**:1-43

[16] Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nature Reviews.

[17] Brousset P, Knecht H, Rubin B, Drouet E, Chittal S, Meggetto F, et al. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood. 1993;**82**:872-876

[18] Brousset P, Drouet E, Schlaifer D, Icart J, Payen C, Meggetto F, et al.

Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDSrelated non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV. AIDS. 1994;**8**:583-590

Virology. 2018;**32**:60-70

Cancer. 2004;**4**:757-768

*DOI: http://dx.doi.org/10.5772/intechopen.88607*

[1] Longnecker RM, Kieff E, Cohen JI. Epstein-Barr virus. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia, Pa: Lippincott-Williams Wilkins Publishers; 2013. pp. 1898-1960

[2] Joseph AM, Babcock GJ, Thorley-Lawson DA. EBV persistence involves strict selection of latently infected B cells. Journal of Immunology.

[3] Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity.

[4] Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Journal of Virology.

[5] Li QX, Young LS, Niedobitek G, Dawson CW, Birkenbach M, Wang F, et al. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 1992;**356**:347-350

[6] Takada K, Shimizu N, Sakuma S, Ono Y. Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. Journal of Virology. 1986;**57**:1016-1022

[7] Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. Journal of

[8] Kenney SC, Mertz JE. Regulation of the latent-lytic switch in Epstein-Barr virus. Seminars in Cancer Biology.

[9] Tsurumi T, Fujita M, Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Reviews in Medical Virology.

Virology. 2005;**79**:1296-1307

**References**

2000;**165**:2975-2981

1998;**9**:395-404

1992;**66**:122-131

*The Role of the Epstein-Barr Virus Lytic Cycle in Tumor Progression: Consequences in Diagnosis… DOI: http://dx.doi.org/10.5772/intechopen.88607*
